Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Image Analysis

By Drug Discovery Trends Editor | November 12, 2007

Fujifilm Life Science LAS-4000Fujifilm Life Science offers the LAS-4000, a luminescent image analyzer suited for multi-spectral Western blotting and in vivo imaging of small animals with expanded fluorescent capabilities. The LAS-4000 is the latest version in Fujifilm’s LAS line of CCD-based camera systems.

Additional light sources, most notably epi-ultraviolet (UV) and epi-near-infrared (IR) illuminators, coupled with in vivo imaging of small animal samples distinguish the LAS-4000 from its predecessor, the LAS-3000. The UV light source gives researchers the ability to use quantum dots for in vitro applications like multi-spectral Western blotting. IR capabilities enable deeper penetration of excitation light for high-sensitivity small animal in vivo imaging using longer wavelength fluorochromes like Cy7 and Alexa Fluor 750.

Additional features of the LAS-4000 include six interchangeable light sources, a five-position filter turret and a 3.2 megapixel Super CCD imaging chip cooled to -30 degrees Celsius for decreased noise during longer exposures. The FUJINON lens, with an F-stop number of 0.85, can capture images from distances as short as several tens of centimeters.

https://www.fujifilmlifescienceusa.com/

Published in Drug Discovery & Development magazine: Vol. 10, No. 11, November, 2007, p.8.


Filed Under: Drug Discovery

 

Related Articles Read More >

EVEREST lead investigator on why Dupixent sets a new bar for treating coexisting CRSwNP and asthma
Sanders, King target DTC pharma ads but the industry worries more about threats to its $2B R&D model
Zoliflodacin wins FDA nod for treatment of gonorrhea
FDA approved ENFLONSIA for the prevention of RSV in Infants
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE